Search Results
Search for other papers by Andrew McDonald in
Google Scholar
PubMed
Search for other papers by Vaidehi Avadhani in
Google Scholar
PubMed
Search for other papers by Gabriela Oprea-Ilies in
Google Scholar
PubMed
Search for other papers by Katerina Zakka in
Google Scholar
PubMed
Search for other papers by Gregory B Lesinski in
Google Scholar
PubMed
Search for other papers by Olumide B Gbolahan in
Google Scholar
PubMed
Search for other papers by Olatunji Alese in
Google Scholar
PubMed
as neuroendocrine carcinoma (NEC). There is an inverse correlation between overall survival (OS) and tumor grade, with HG NEC having the worst prognosis among GEP-NEN subtypes ( Klimstra et al. 2019 ). GEP-NECs have an aggressive natural history
Search for other papers by Paul C Marker in
Google Scholar
PubMed
Search for other papers by Christopher J Unterberger in
Google Scholar
PubMed
Search for other papers by Steven M Swanson in
Google Scholar
PubMed
and rats where changes in the activity of GH and/or mediators of GH action have altered the initiation and/or progression of experimentally induced carcinomas. Early evidence that GH could promote carcinogenesis came from chronic injection of rats with
Search for other papers by T M A Kerkhofs in
Google Scholar
PubMed
Search for other papers by M H T Ettaieb in
Google Scholar
PubMed
Search for other papers by I G C Hermsen in
Google Scholar
PubMed
Department of Internal Medicine, Division of General Internal Medicine, Department of Health Services Research and CAPHRI School for Public Health and Primary Care, Maxima Medical Center, Ds. Th. Fliednerstraat 1, 5631 BM Eindhoven/Veldhoven, The Netherlands
Department of Internal Medicine, Division of General Internal Medicine, Department of Health Services Research and CAPHRI School for Public Health and Primary Care, Maxima Medical Center, Ds. Th. Fliednerstraat 1, 5631 BM Eindhoven/Veldhoven, The Netherlands
Search for other papers by H R Haak in
Google Scholar
PubMed
with suspect adrenocortical carcinoma. Clinical prognostic factors Currently, the most important prognostic factor in ACC is the stage of disease at presentation ( Fassnacht et al . 2009 ). The European Network for the Study of Adrenal Tumours (ENSAT
Search for other papers by Jae Hyun Park in
Google Scholar
PubMed
Search for other papers by Jong Ho Yoon in
Google Scholar
PubMed
Introduction Surgical treatment for a differentiated thyroid carcinoma (DTC) derived from follicular cells is a starting point of a multifaceted treatment approach. Even though DTC is generally non-aggressive and has good prognosis, choosing
School of Health Sciences, ICVS/3B's – PT Government Associate Laboratory, IPATIMUP – Institute of Molecular Pathology and Immunology, Medical Faculty, Department of Laboratory Medicine and Pathobiology, Department of Pathology, Barretos School of Health Sciences, Life and Health Sciences Research Institute (ICVS), University of Minho, Campus of Gualtar, Braga, Portugal
Search for other papers by Filipa Morais-Santos in
Google Scholar
PubMed
School of Health Sciences, ICVS/3B's – PT Government Associate Laboratory, IPATIMUP – Institute of Molecular Pathology and Immunology, Medical Faculty, Department of Laboratory Medicine and Pathobiology, Department of Pathology, Barretos School of Health Sciences, Life and Health Sciences Research Institute (ICVS), University of Minho, Campus of Gualtar, Braga, Portugal
Search for other papers by Vera Miranda-Gonçalves in
Google Scholar
PubMed
School of Health Sciences, ICVS/3B's – PT Government Associate Laboratory, IPATIMUP – Institute of Molecular Pathology and Immunology, Medical Faculty, Department of Laboratory Medicine and Pathobiology, Department of Pathology, Barretos School of Health Sciences, Life and Health Sciences Research Institute (ICVS), University of Minho, Campus of Gualtar, Braga, Portugal
Search for other papers by Sílvia Pinheiro in
Google Scholar
PubMed
Search for other papers by André F Vieira in
Google Scholar
PubMed
Search for other papers by Joana Paredes in
Google Scholar
PubMed
School of Health Sciences, ICVS/3B's – PT Government Associate Laboratory, IPATIMUP – Institute of Molecular Pathology and Immunology, Medical Faculty, Department of Laboratory Medicine and Pathobiology, Department of Pathology, Barretos School of Health Sciences, Life and Health Sciences Research Institute (ICVS), University of Minho, Campus of Gualtar, Braga, Portugal
School of Health Sciences, ICVS/3B's – PT Government Associate Laboratory, IPATIMUP – Institute of Molecular Pathology and Immunology, Medical Faculty, Department of Laboratory Medicine and Pathobiology, Department of Pathology, Barretos School of Health Sciences, Life and Health Sciences Research Institute (ICVS), University of Minho, Campus of Gualtar, Braga, Portugal
School of Health Sciences, ICVS/3B's – PT Government Associate Laboratory, IPATIMUP – Institute of Molecular Pathology and Immunology, Medical Faculty, Department of Laboratory Medicine and Pathobiology, Department of Pathology, Barretos School of Health Sciences, Life and Health Sciences Research Institute (ICVS), University of Minho, Campus of Gualtar, Braga, Portugal
Search for other papers by Fernando C Schmitt in
Google Scholar
PubMed
School of Health Sciences, ICVS/3B's – PT Government Associate Laboratory, IPATIMUP – Institute of Molecular Pathology and Immunology, Medical Faculty, Department of Laboratory Medicine and Pathobiology, Department of Pathology, Barretos School of Health Sciences, Life and Health Sciences Research Institute (ICVS), University of Minho, Campus of Gualtar, Braga, Portugal
Search for other papers by Fátima Baltazar in
Google Scholar
PubMed
School of Health Sciences, ICVS/3B's – PT Government Associate Laboratory, IPATIMUP – Institute of Molecular Pathology and Immunology, Medical Faculty, Department of Laboratory Medicine and Pathobiology, Department of Pathology, Barretos School of Health Sciences, Life and Health Sciences Research Institute (ICVS), University of Minho, Campus of Gualtar, Braga, Portugal
School of Health Sciences, ICVS/3B's – PT Government Associate Laboratory, IPATIMUP – Institute of Molecular Pathology and Immunology, Medical Faculty, Department of Laboratory Medicine and Pathobiology, Department of Pathology, Barretos School of Health Sciences, Life and Health Sciences Research Institute (ICVS), University of Minho, Campus of Gualtar, Braga, Portugal
Search for other papers by Céline Pinheiro in
Google Scholar
PubMed
, 2010 , de Oliveira et al . 2012 ), reinforcing the potential of MCT1 as a cancer therapeutic target. Recently, our group described an increase in MCT1 expression in breast carcinomas, when compared with normal tissue. This enhanced MCT1 expression, as
Search for other papers by Giada Poli in
Google Scholar
PubMed
Search for other papers by Daniele Guasti in
Google Scholar
PubMed
Search for other papers by Elena Rapizzi in
Google Scholar
PubMed
Search for other papers by Rossella Fucci in
Google Scholar
PubMed
Search for other papers by Letizia Canu in
Google Scholar
PubMed
Search for other papers by Alessandra Bandinelli in
Google Scholar
PubMed
Search for other papers by Nicoletta Cini in
Google Scholar
PubMed
Search for other papers by Daniele Bani in
Google Scholar
PubMed
Endocrinology Unit, Research Unit of Histology and Embryology, Laboratorio Generale, Istituto Toscano Tumori, Department of Experimental and Clinical Biomedical Sciences
Search for other papers by Massimo Mannelli in
Google Scholar
PubMed
Search for other papers by Michaela Luconi in
Google Scholar
PubMed
Introduction Adrenocortical carcinoma (ACC) is a rare and aggressive endocrine tumor with an incidence of 0.5–2 cases per million people every year. ACC prognosis is mainly dependent on the stage at diagnosis ( Fassnacht et al . 2009 ), with the
Search for other papers by Xi Zhang in
Google Scholar
PubMed
Search for other papers by Vijay Pandey in
Google Scholar
PubMed
Search for other papers by Vipul Bhardwaj in
Google Scholar
PubMed
Department of Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, P R China
The CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, P R China
Search for other papers by Tao Zhu in
Google Scholar
PubMed
Tsinghua Berkeley Shenzhen Institute and Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, P R China
Search for other papers by Peter E Lobie in
Google Scholar
PubMed
precluded definitive demonstration that hGH was actually synthesized and secreted in extrapituitary cancer. As an endocrine hormone, immunohistochemical detection of hGH in carcinoma cells in histopathological sections could be, and initially was
Department of Breast, Endocrine Tumours and Sarcoma, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Johan O Paulsson in
Google Scholar
PubMed
Search for other papers by Na Wang in
Google Scholar
PubMed
Search for other papers by Jiwei Gao in
Google Scholar
PubMed
Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Department of Breast, Endocrine Tumours and Sarcoma, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Adam Stenman in
Google Scholar
PubMed
Department of Breast, Endocrine Tumours and Sarcoma, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Jan Zedenius in
Google Scholar
PubMed
Search for other papers by Ninni Mu in
Google Scholar
PubMed
Search for other papers by Weng-Onn Lui in
Google Scholar
PubMed
Search for other papers by Catharina Larsson in
Google Scholar
PubMed
Department of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by C Christofer Juhlin in
Google Scholar
PubMed
the last few decades, especially since the beginning of the 1990s, but the mortality rate has remained relatively stable ( Kitahara & Sosa 2016 ). The increase is mainly attributable to the increasing incidence of papillary thyroid carcinoma (PTC), but
Search for other papers by S G Creemers in
Google Scholar
PubMed
Search for other papers by P M van Koetsveld in
Google Scholar
PubMed
Search for other papers by W W De Herder in
Google Scholar
PubMed
Search for other papers by F Dogan in
Google Scholar
PubMed
Search for other papers by G J H Franssen in
Google Scholar
PubMed
Search for other papers by R A Feelders in
Google Scholar
PubMed
Search for other papers by L J Hofland in
Google Scholar
PubMed
Introduction Adrenocortical carcinoma (ACC) is a highly malignant disease with limited treatment options ( Creemers et al. 2016 a ). The only curative treatment is tumor-directed surgery (R0 resection) in case of local disease. The high
Search for other papers by Yoshiaki Onodera in
Google Scholar
PubMed
Search for other papers by Hozumi Motohashi in
Google Scholar
PubMed
Search for other papers by Kiyoshi Takagi in
Google Scholar
PubMed
Search for other papers by Yasuhiro Miki in
Google Scholar
PubMed
Search for other papers by Yukiko Shibahara in
Google Scholar
PubMed
Search for other papers by Mika Watanabe in
Google Scholar
PubMed
Search for other papers by Takanori Ishida in
Google Scholar
PubMed
Search for other papers by Hisashi Hirakawa in
Google Scholar
PubMed
Department of Anatomic Pathology, Department of Gene Expression Regulation, Department of Pathology and Histotechnology, Department of Pathology, Department of Surgical Oncology, Department of Surgery, Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan
Search for other papers by Hironobu Sasano in
Google Scholar
PubMed
Search for other papers by Masayuki Yamamoto in
Google Scholar
PubMed
Search for other papers by Takashi Suzuki in
Google Scholar
PubMed
markedly influenced predominantly by the proliferative activity of the carcinoma cells ( van Diest et al . 2004 ). Nevertheless, breast cancer patients frequently received adjuvant therapy such as endocrine therapy (tamoxifen, luteinizing hormone